阈下抑郁心理干预的个体参与者数据荟萃分析:疗效与调节因素
该研究通过个体参与者数据荟萃分析发现,心理干预对阈下抑郁成人 depressive 症状严重程度在12个月内有效(s.m.d.=-0.48至-0.27),24个月效果不确定(s.m.d.=-0.18)。基线抑郁和焦虑严重程度是可信的调节因素,PHQ-9=5时预测效应为s.m.d.=-0.33。
要点
- 心理干预改善阈下抑郁症状达12个月,并降低恶化风险。
- 基线抑郁和焦虑严重程度是可信的效应调节因素。
- PHQ-9≥10者获益更强,极轻症状(PHQ-9=5)仍有微小重要效应。
核心结论
- 心理干预可减轻阈下抑郁个体至1年的症状负担并防止症状恶化,但2年获益不确定性较高。
- 强烈支持对阈下抑郁进行干预,尤其是PHQ-9评分≥10者;极轻症状者可考虑可扩展的治疗方案。
研究设计与样本
- 系统检索比较心理干预与无活性对照的随机试验,联系作者获取个体参与者数据(IPD)。
主要发现
- 至12个月时对抑郁症状严重程度有显著效应(s.m.d.=-0.48至-0.27),24个月效应无法确定(s.m.d.=-0.18)。
- 50%症状减轻的相对风险为1.27-2.79,可靠改善的相对风险为1.38-3.17。
- 症状恶化的相对风险为0.67-0.54,接近无症状状态的相对风险为1.41-2.80。
- 参与者水平调节因素中仅基线抑郁和焦虑严重程度高度可信(P>0.99)。
- 预测治疗获益随症状严重程度降低而减小,但极轻症状(PHQ-9=5)仍有s.m.d.=-0.33。
关键数值与推荐
- 12个月内抑郁症状严重程度效应量s.m.d.=-0.48至-0.27;24个月s.m.d.=-0.18。
- 50%症状减轻相对风险1.27-2.79;可靠改善相对风险1.38-3.17;恶化相对风险0.67-0.54;接近无症状相对风险1.41-2.80。
- 基线抑郁和焦虑严重程度作为调节因素的证据高度可信(P>0.99)。
- PHQ-9=5时预测效应s.m.d.=-0.33;PHQ-9≥10者强烈支持干预。
临床怎么用
- 对阈下抑郁成人可提供心理干预以减轻症状并预防恶化,尤其PHQ-9≥10者。
- 极轻症状(如PHQ-9=5)者仍可考虑可扩展的心理干预方案。
- 干预效果随基线症状严重程度降低而减小,临床决策需结合症状水平个体化。
局限性
- 24个月长期效果无法确定,仅能确认至12个月的效应。
- 仅基线抑郁和焦虑严重程度为高度可信的调节因素,其他参与者水平调节因素未获强支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It remains unclear which individuals with subthreshold depression benefit most from psychological intervention, and what long-term effects this has on symptom deterioration, response and remission. AIMS: To synthesise psychological intervention benefits in adults with subthreshold depression up to 2 years, and explore participant-level effect-modifiers. METHOD: Randomised trials comparing psychological intervention with inactive control were identified via systematic search. Authors were contacted to obtain individual participant data (IPD), analysed using Bayesian one-stage meta-analysis. Treatment-covariate interactions were added to examine moderators. Hierarchical-additive models were used to explore treatment benefits conditional on baseline Patient Health Questionnaire 9 (PHQ-9) values. RESULTS: IPD of 10 671 individuals (50 studies) could be included. We found significant effects on depressive symptom severity up to 12 months (standardised mean-difference [s.m.d.] = -0.48 to -0.27). Effects could not be ascertained up to 24 months (s.m.d. = -0.18). Similar findings emerged for 50% symptom reduction (relative risk = 1.27-2.79), reliable improvement (relative risk = 1.38-3.17), deterioration (relative risk = 0.67-0.54) and close-to-symptom-free status (relative risk = 1.41-2.80). Among participant-level moderators, only initial depression and anxiety severity were highly credible (P > 0.99). Predicted treatment benefits decreased with lower symptom severity but remained minimally important even for very mild symptoms (s.m.d. = -0.33 for PHQ-9 = 5). CONCLUSIONS: Psychological intervention reduces the symptom burden in individuals with subthreshold depression up to 1 year, and protects against symptom deterioration. Benefits up to 2 years are less certain. We find strong support for intervention in subthreshold depression, particularly with PHQ-9 scores ≥ 10. For very mild symptoms, scalable treatments could be an attractive option.
引用
- Harrer M, Sprenger AA, Illing S, et al. Psychological intervention in individuals with subthreshold depression: individual participant data meta-analysis of treatment effects and moderators. Br J Psychiatry. 2025. PMID: 40365980. doi:10.1192/bjp.2025.56
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。